AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06551974 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Guided self-help plus IPT
Description: The participants allocated in the intervention GSH arm will have access to self-help materials (workbook and videoclips), forum groups (interactional materials), online interpersonal group sessions for 8 weeks. The proposed online GSH will be adapted from two online interventions developed and tested with people with eating disorders by the Eating Disorders Research Unit team at King's College London, with a cooperation of the University of Palermo research team (Cardi et al., 2020). The GSH will include self-help materials, i.e. a written workbook and a library of 74 brief video-clips with the goal of providing psychoeducation about eating disorders and interpersonal difficulties and describing and modelling the use of helpful strategies to reverse abnormal eating behaviours. Participants will also attend a weekly online forum with interactional materials, and an online interpersonal group session.
Study NCT06551974 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Guided self-help
Description: The participants allocated in the intervention GSH arm will have access to self-help materials (workbook and videoclips), forum groups (interactional materials), online interpersonal group sessions for 8 weeks. The proposed online GSH will be adapted from two online interventions developed and tested with people with eating disorders by the Eating Disorders Research Unit team at King's College London, with a cooperation of the University of Palermo research team (Cardi et al., 2020). The GSH will include self-help materials, i.e. a written workbook and a library of 74 brief video-clips with the goal of providing psychoeducation about eating disorders and interpersonal difficulties and describing and modelling the use of helpful strategies to reverse abnormal eating behaviours.
Study NCT06551974 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TAU
Description: The Treatment as Usual is the usual or routine care provided to participants in the outpatient setting.
Study NCT06496048 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lurbinectedin
Description: Lurbinectedin 3.2 mg/m2 administered by infusion on Day 1 of each cycle (q3wk)
Study NCT06496048 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan
Description: Irinotecan 75 mg/m² intravenously Days 1 \& 8 q3wk
Study NCT06496048 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lurbinectedin
Description: Lurbinectedin 2.0 mg/m2 administered by infusion on Day 1 of each cycle (q3wk)
Study NCT06496048 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topotecan
Description: Topotecan 1.2 mg/m² intravenously Days 1-5 q3wk
Study NCT04934423 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Direct Current Transcranial Stimulation - tDCS
Description: Active intervention
Study NCT04934423 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Intervention
Description: Direct Current Transcranial Stimulation - Sham intervention
Study NCT04481737 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer-delivered and Technology Support Integrated Illness Management and Recovery
Description: PDTA-IIMR is delivered by a peer support specialist with the use of guided IIMR eModules and a smartphone application designed to complement in-person eModule sessions. The eModules are designed to be reviewed with a peer support specialist and consumer during one-hour, weekly, telephonic sessions in a community setting. Each eModule includes videos and experiential learning tasks on psychoeducation and coping skills training.
Study NCT04481737 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Peer support
Description: Peer support is a non-manualized form of social support, frequently coupled with instrumental support, that is mutually offered or provided by persons having a mental health condition to others sharing a similar mental health condition to bring about a desired social or personal change. Peer support specialists are provided with 1-hour of supervision each week
Study NCT04852536 — intervention group
Intervention type: DEVICE
Intervention: Neurostimulation (High Definition - transcranial Direct Current Stimulation) HD-tDCS
Description: 5 consecutive sessions lasting 20 minutes of HD-tDCS4x1, based on previous publications (VILLAMAR et al., 2013). A list will be provided current of 2 mA, placing a central electrode (anode) on the M1 contralateral to the painful limb and the four return electrodes within a radius of 7.5 cm around, corresponding approximately to Cz, F3, T7 and P3 if the stimulation is on the side left, and Cz, F4, T8 and P4 if it is on the right, according to the International 10/20 System.
Study NCT05586152 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INV-102
Description: INV-102 Ophthalmic Solution
Study NCT05586152 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle
Description: Vehicle Ophthalmic Solution
Study NCT06166446 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: subtractive technique
Description: The milled denture teeth are then bonded into the milled recesses using a special PMMA bonding system.
Study NCT06166446 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: additive technique
Description: The denture teeth were printed as one unit using the same method with tooth resin (DENTCA Denture Tooth, Shade A2).
Study NCT06467422 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tTIS on dACC, theta frequency (5 Hz)
Description: Device: Transcranial electric stimulation device~The first pair of electrodes continuously outputs a current with a frequency of f1 = 2 kHz, while the second pair continuously outputs a current with a frequency of f2 = 2.006 kHz. According to the principle of time-domain coherence, an alternating electric field with a frequency of f2-f1 = 6 Hz can be generated in the target area. The experimental group receives a stimulation intensity of 2mA for 20 minutes. The optimal electrode position and current parameters are determined by using the MIDA head electric field model.
Study NCT06467422 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: tTIS on dACC, High frequency
Description: The first pair of electrodes continuously outputs a current with a frequency of f1 = 2 kHz, while the second pair continuously outputs a current with a frequency of f2 = 2 kHz. The sham group receives a stimulation intensity of 2mA for 20 minutes. The optimal electrode position and current parameters are determined by using the MIDA head electric field model.
Study NCT06205342 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mesenchymal Stem Cells
Description: Autologous bone marrow derived MSCs
Study NCT06205342 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Other: Placebo
Description: Control
Study NCT05666453 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LIV-GAMMA SN Inj.
Description: LIV-GAMMA SN Inj. is administered at a dose of 0.6 g/kg/day from anhepatic phase to Day 2 post-operative to patients undergoing ABO-incompatible liver transplantation as an experimental group.
Study NCT05666453 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No intervention
Description: None of investigational drugs are administered to patients.
Study NCT04991467 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CARE Program and Valera Application with care manager functionality
Description: Participant will take part in 12 week CARE program and receive the Valera health application which will provide parent education materials as well as the ability to connect to their child's treatment team via care manager.
Study NCT04991467 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Valera Application with care manager functionality
Description: Participant will receive the Valera health application which will provide parent education materials and the ability to connect to their child's treatment team via care manger.
Study NCT04991467 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CARE Program
Description: Participant will take part in 12 week CARE program.
Study NCT04991467 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Valera Application
Description: Participant will receive the Valera health application which will provide parent education materials.
Study NCT04991467 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CARE Program and Valera Application
Description: Participant will take part in 12 week CARE program and receive the Valera health application which will provide parent education materials.
Study NCT06448754 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Volrustomig
Description: Participants will receive volrustomig via intravenous (IV) infusion.
Study NCT04715607 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Sequence of testing.
Description: The participants will be tested in the following sequences of sampling technique: (1) nasopharyngeal swab, oropharyngeal swab, and salvia collection OR (2) oropharyngeal swab, salvia collection, and nasopharyngeal swab OR (3) salvia collection, nasopharyngeal swab, and oropharyngeal swab. Only the sequence is different in the different arm, while the sampling technique for each method is the same in all arms.
Study NCT06448754 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Participants will receive carboplatin via IV infusion.
Study NCT06448754 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Participants will receive pemetrexed via IV infusion.
Study NCT06017219 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: spermidine
Description: spermidine
Study NCT06297486 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: SPK-8011
Description: Participants will receive a single dose of SPK-8011, administered by intravenous (IV) infusion, on Day 1.
Study NCT04752423 — intervention group
Intervention type: OTHER
Intervention: Pre operative assessment
Description: Anxiety assessment : Numeric rating scale (patient and caregiver), APAIS scale (patient), Covi Scale (Caregiver)~Verbalization : anesthesia-related concerns (expressed by patient and considered by caregiver)
Study NCT06367166 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venarus® (diosmin and hesperidin)
Description: Venarus® (diosmin and hesperidin) at a dosage of 1000 mg once daily for 6 months
Study NCT06367166 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endovenous laser ablation (EVLA) with miniphlebectomy
Description: Endovenous laser ablation will be performed under local and tumescent anesthesia, laser wavelength 1470nm.
Study NCT06367166 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Elastic compression
Description: All subject with varicose veins enrolled in the study will receive class 2 elastic compression (elastic stockings) after enrollment
Study NCT06367166 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Evaluation of biomarkers of venous wall remodeling (fibronectin, PAI-1, vimentin, vWF, CD31), venous symptoms and severity scores
Description: The patients and healthy volunteers will undergo evaluation of biomarkers of venous wall remodeling (fibronectin, PAI-1, vimentin, vWF, CD31), Venous clinical severity (VCS) score, Visual Analog Scale (VAS) score and 20 item-ChronIc Venous dIsease quality-of-life Questionnaire (CIVIQ-20) at baseline, and 2, 3, and 6 months after enrollment
Study NCT06177665 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block
Description: Ultrasound(US)-guided erector spinae plan block(ESP) with 20 ml 0,25% bupivacaine at T4 vertebra level will performe preoperatively to all patients in the ESP group.
Study NCT06177665 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rhomboid Intercostal Block
Description: Ultrasound(US)-guided rhomboid intercostal block(RIB) with 20 ml 0,25% bupivacaine at T5-T6 vertebra level will performe preoperatively to all patients in the RIB group.
Study NCT06211569 — intervention group
Intervention type: OTHER
Intervention: Usual follow-up
Description: Usual follow-up
Study NCT04853810 — intervention group
Intervention type: OTHER
Intervention: CUTADIAB questionnaire
Description: During a regular diabetes follow-up consultation, the patient is asked to complete the CUTADIAB questionnaire on a tablet, entirely dedicated to the study
Study NCT06173245 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intravitreal injection of ranibizumab
Description: These patients were received three intravitreal injection of ranibizumab with one month interval. 3D-OCT by enhanced depth spectral-domain imaging (EDI-OCT) was done preoperative and a month after every injection.~All patients recieved topical anesthesia as 0.5 mg/0.05 ml , ranibizumab is injected 4 mm (3.5 mm in Pseudophakia) from the limbus intravitreally (in the lower temporal quadrant) by a needle (27gauge).
Study NCT05181982 — intervention group
Intervention type: OTHER
Intervention: FIT contract with global treatment budget
Description: Several SHI funds have established a contract (duration = at least eight year) with the model hospital for an alternative remuneration / financing of patients treated in the model hospital (FIT hospital, Pfalzklinikum). This contract encourages the model hospital an alternative treatment of their patients (insured with the involved SHI funds), for example fewer inpatient and more outpatient treatment. The contract is based on a global treatment budget (pre-defined fix budget for a specified number of patients independent from the setting of treatment in the hospital).
Study NCT05918068 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin 500 mg/day
Description: Metformin 500 mg/day in addition to non-pharmacological therapy
Study NCT05918068 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin 500 mg/day
Description: Metformin 500 mg/day in addition to non-pharmacological therapy
Study NCT05630261 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-help CBT-I
Description: The intervention will cover the following topics: (a) physiological linkage between the brain and stress, (b) sleep hygiene, (c) stimulus control, (d) sleep restriction, (e) cognitive restructuring, and (f) positive psychology. Each weekly session will be divided into 6-8 chapters. Chapters are supported by short videos and interactive games. Homework activities will be assigned after each session.
Study NCT05630261 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-help CBT-D
Description: The intervention will cover the following topics: (a) physiological linkage between the brain and stress, (b) emotion management, (c) cognitive restructuring, (d) behavioral activation, and (e) positive psychology. Each weekly session will be divided into 6-8 chapters. Some chapters are supported by short videos and e-worksheets. Homework activities will be assigned after each session, which include weekly record of emotions or between-session practice.
Study NCT05918068 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Metformin 500 mg/day plus vitamin B6 300 mg/day
Description: Metformin 500 mg/day plus vitamin B6 300 mg/day in addition to non-pharmacological therapy
Study NCT05918068 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: non-pharmacological therapy
Description: non-pharmacological therapy (healthy lifestyle modifications)
Study NCT05918068 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: non-pharmacological therapy
Description: non-pharmacological therapy (healthy lifestyle modifications)
Study NCT05918068 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: non-pharmacological therapy
Description: non-pharmacological therapy (healthy lifestyle modifications)
Study NCT05591339 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCG vaccine (two doses, 4 weeks apart)
Description: BCG vaccine provided intradermally at the upper arm.
Study NCT05591339 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Saline placebo (Two doses, 4 weeks apart)
Description: Participants randomized to the control group (placebo) will receive one 0.1 ml dose sterile 0.9 % NaCl by intradermal injection in the left deltoid region.
Study NCT04216316 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Berzosertib
Description: Given IV
Study NCT04216316 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Correlative studies
Study NCT04216316 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Correlative studies
Study NCT04216316 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV
Study NCT04216316 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Given IV
Study NCT04216316 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT04216316 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT
Study NCT04216316 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine Hydrochloride
Description: Given IV
Study NCT04216316 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine Hydrochloride
Description: Given IV
Study NCT06576700 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Grape Seed Extracts
Description: 2 capsules/day for 8 weeks
Study NCT06339944 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sensory motor training
Description: in this group 17 participants will receive conventional therapy and then followed by kinesthetic exercises. 3 sessions per week includes 10 repetitions with 3sets.
Study NCT04216316 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT04216316 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT04216316 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV
Study NCT04216316 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Pembrolizumab
Description: Given IV
Study NCT06432517 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Power Bike（Ergoselect 100P）
Description: Changes in the participants' energy balance will be measured through moderate to high intensity exercise. Observation of food intake, body composition, metabolic rate, food assimilation rate.
Study NCT06339944 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: kinesthetic exercises
Description: in this group 17 participants will receive conventional therapy and then followed by kinesthetic exercises. 3 sessions per week includes 10 repetitions with 3sets.
Study NCT05271149 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Routine Physical Therapy
Description: Routine physical therapy and orthosis
Study NCT05271149 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine Physical Therapy
Description: Routine physical therapy and orthosis
Study NCT05393869 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health communications
Description: Participants are assigned to view health communications with risk and efficacy statements.
Study NCT05393869 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Health communications
Description: Participants are assigned to view health communications with risk and efficacy statements.
Study NCT06252558 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Symbiotic
Description: One-a-day administration of a capsule supplement containing:15 billion CFU probiotic blend (Lactobacillus acidophilus La-14, Bifidobacterium longum BB536, Lactobacillus acidophilus NCFM, Lactobacillus rhamnosus GG, Lactobacillus gasseri Lg-36) and 250mg of chicory root inulin.
Study NCT06252558 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Daily fiber capsule containing microcrystalline cellulose
Study NCT05698381 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Liquid vinegar
Description: 2 tablespoons consumed twice daily with meals
Study NCT05698381 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Vinegar pill
Description: 2 pills consumed upon waking
Study NCT04562649 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wise App with medication adherence reminders
Description: The Intervention group will receive the Wise App that delivers medication adherence reminders.
Study NCT04562649 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CHW Sessions
Description: The Intervention group will complete sessions with a community health worker (CHW).
Study NCT06262698 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experiment group
Description: The experimental group will receive six weeks of HBM-based training.
Study NCT06262698 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Pre-post test
Description: The TCM Attitude Scale (CACMAS), Medication Health Belief Scale
Study NCT06262698 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pre-post test
Description: The TCM Attitude Scale (CACMAS), Medication Health Belief Scale
Study NCT05432271 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure to calorie information
Description: Calories for all beverages and foods
Study NCT05432271 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exposure to calorie information
Description: Calories for all beverages and foods